Clinical Activity of REGN1979, a Bispecific Human, Anti-CD20 x Anti-CD3 Antibody, in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)Rajat Bannerji, Max S. Topp, Ranjana H. Advani et al.|Blood|2019Cited by 57
Phase 1 Study of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Monoclonal Antibody, in Patients with CD20+ B-Cell Malignancies Previously Treated with CD20-Directed Antibody TherapyRajat Bannerji, Carrie Brownstein, Jennifer R. Brown et al.|Blood|2016Cited by 19